A new report assesses the viability of new healthcare expansion options with Medicaid insurers.
Mona Shah
If Medicaid managed care plans offer coverage to more people and in more places, it could help protect consumers from higher healthcare costs, according to a new report.
The number of insurers participating in ACA individual insurance marketplaces has decreased over time, reveals a new report from the Urban Institute, with support from the Robert Wood Johnson Foundation (RWJF). Fewer insurers often leads to higher premiums for enrollees.
Related: The Future of the ACA
“This study looks at the possibility of convincing more Medicaid insurers to participate in the marketplaces and the impact that would have on lowering marketplace premiums,” says Mona Shah, senior program officer at RWJF. “Some Medicaid insurers have found that participation in the marketplace have expanded their footprints to new states and markets.”
Key findings include:
Generally, interviewees were in favor of Medicaid buy-in proposals, according to Shah. “These plans could allow Medicaid beneficiaries to retain continuous coverage year-round who may otherwise come on and off insurer’s Medicaid plans, as individuals’ incomes rise and fall,” she says.
Related: Top Medicaid Trends in 2019
The findings suggest that the closer Medicaid buy-in proposals hew to Medicaid program rules, the more likely that Medicaid insurers would participate in such programs, according to Shah.
There are three top reasons Medicaid insurers do not sell plans in ACA marketplaces, according to Shah:
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
In our latest "Meet the Board" podcast episode, Managed Healthcare Executive Editors caught up with editorial advisory board member, Eric Hunter, CEO of CareOregon, to discuss a number of topics, one including the merger that never closed with SCAN Health Plan due to local opposition from Oregonians.
Listen
Positive Pipeline Updates for Friedreich’s Ataxia
October 24th 2024After experiencing setbacks, PTC reported positive results for vatiquinone, its selective inhibitor of 15-Lipoxygenase (15-LO) enzyme, regulator of the energetic and oxidative stress pathways that are disrupted in Friedreich ataxia
Read More